Thiomorpholine → HCID 11165348, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:8]#[C:9][C:10]2[N:11]=[C:12]([CH3:22])[N:13]([C:15]3[CH:20]=[CH:19][CH:18]=[C:17](F)[N:16]=3)[CH:14]=2)[CH:5]=[CH:6][CH:7]=1.[NH:23]1[CH2:28][CH2:27][S:26][CH2:25][CH2:24]1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:8]#[C:9][C:10]2[N:11]=[C:12]([CH3:22])[N:13]([C:15]3[N:16]=[C:17]([N:23]4[CH2:28][CH2:27][S:26][CH2:25][CH2:24]4)[CH:18]=[CH:19][CH:20]=3)[CH:14]=2)[CH:5]=[CH:6][CH:7]=1Participants
3
Procedure
The title compound, MS: m/e=395.1, 397.1 (M+H+), was prepared in accordance with the general method of example 27 from 2-[4-(3-chloro-phenylethynyl)-2-methylimidazol-1-yl]-6-fluoro-pyridine and thiomorpholine.
Sources & evidence
- ORD record
- ord-817a283d94a4480ea1deceddfdb69838
- Source dataset
- uspto-grants-2007_07
- Patent number
- US07241760B2
Reaction notes
Loading…